Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhengchaihu Granules (正柴胡饮颗粒) is a traditional Chinese medicine (TCM) product manufactured by Nantong Pharmaceutical Factory, a subsidiary of Jinghua Pharmaceutical Group. It is an antipyretic and analgesic formulation used to treat the wind-cold type of common cold and influenza. The product is based on a classic TCM formula and contains extracts from six herbal ingredients: Bupleurum (Chaihu), Saposhnikovia root (Fangfeng), Tangerine peel (Chenpi), Red Peony root (Chishao), Licorice (Gancao), and Fresh Ginger (Shengjiang). It is indicated for symptoms including fever, chills, headache, nasal congestion, sneezing, and cough. Zhengchaihu Granules is an approved over-the-counter (OTC) medication in China and is frequently included in national treatment guidelines for respiratory viral infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zhengchaihu granules.